About Aardvark Therapeutics
Aardvark Therapeutics is a private company based in San Diego, California. It has reported $103,059,985 raised in three offerings on Form D since May 2019. Its chief executive is Tien-Li Lee.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 1, 2024 | May 15, 2024 | $84,999,982fully sold | 31 | $2.7M | EquityRule 506(b) | Form D ↗ |
| May 26, 2021 | Jun 7, 2021 | $9,060,000of $30.0M target | 8 | $1.1M | EquityRule 506(b) | Form D ↗ |
| May 17, 2019 | May 24, 2019 | $9,000,003of $15.0M target | 12 | $750K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $103,059,985 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aardvark Therapeutics's Form D filed May 15, 2024.
JC
Jeffrey Chi
Director
VT
Victor Tong
Director
NS
Nelson Sun
Executive officer
TL
Tien-Li Lee
CEO and director
Earlier filings also listed Zachary Hornby (director, last listed Jun 2021), Jerel Banks (director, last listed Jun 2021), Henry Ji (director, last listed Jun 2021) and Bob Shin (director, last listed Jun 2021).